ADA’s Scientific Sessions: Takeaways Day 2
The American Diabetes Association’s conference will hear scientists present the latest research, all with the goal of improving lives for the T1D community.
ADA’s Scientific Sessions: Takeaways Day 1
The American Diabetes Association’s conference will hear scientists present the latest research, all with the goal of improving lives for the T1D community.
Breakthrough T1D Heads to ADA’s 83rd Scientific Sessions Diabetes Conference
From June 23-26, Breakthrough T1D researchers will present new study results at the American Diabetes Association's 83rd Scientific Sessions.
Top Type 1 Diabetes Advances of Fiscal Year 2023
Breakthrough T1D highlights the top type 1 diabetes advances we've seen during fiscal year 2023, including cures and life-improving therapies.
A Complication of Type 1: Gastroparesis
Gastroparesis is a condition when the stomach is unable to empty itself properly, leading to problems such as becoming full too early, nausea, and vomiting.
FDA Clears a New Artificial Pancreas System
The FDA cleared the iLet Insulin-Only Bionic Pancreas System for people 6 years of age and older with type 1 diabetes.
Breakthrough T1D Staff Share Personal Stories About Diabetic Eye Disease
Breakthrough T1D staff share their experiences with diabetic eye disease to help raise awareness of the importance of being proactive when it comes to vision health.
FDA Approves Medtronic 780G Artificial Pancreas System
FDA approved the Medtronic 780G artificial pancreas system, providing automatic adjustments and corrections to blood-sugar levels.
Breakthrough T1D Collaboration Leads to Next-Generation Cell Therapy Research
Aspect and Novo Nordisk announce a partnership, using Aspect’s bioprinting technology and Novo Nordisk’s expertise, to develop treatments for diabetes.
A Bittersweet Goodbye for Breakthrough T1D Champion Cynthia Rice
JDRF’s Chief Mission Strategy Officer will leave behind quite a legacy once she steps down from her role at Breakthrough T1D at the end of March 2023.
